Unlock instant, AI-driven research and patent intelligence for your innovation.

Compositions and methods for healing wounds

A composition and wound technology, applied in the direction of drug combination, tissue regeneration, medical science, etc.

Inactive Publication Date: 2018-09-04
韦里格拉福特公司
View PDF15 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, none are optimal for achieving durable wound healing in chronic or acute wounds

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions and methods for healing wounds
  • Compositions and methods for healing wounds
  • Compositions and methods for healing wounds

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0097] Embodiment 1: prepare pigskin skeleton

[0098] Gal / gal pig skin was purchased from Avantea (Cremona, Italy). A piece of skin measuring 20 x 15 cm was dissected from a Gal / gal knockout pig, vacuum sealed into a plastic bag and frozen at -200°C until use. Pig skin was thawed at room temperature, cleaned by excision of subcutaneous fat tissue, hair removed, and finally rinsed with distilled water. The skin was placed in a 5 L plastic container with 0.5% SDS (Sodium Lauryl Sulfate) (Sigma, Germany) containing 0.02% Sodium Azide (Sigma, Germany) and 1.86% EDTA (Alfa Aesar, Germany). 37°C, 200 RPM continuous shaking for 9 days. The SDS is replaced first after 24 hours and then every 48 hours. Each time the SDS was replaced, the skin was washed with distilled water for 1 h.

[0099] Decellularized porcine skin

[0100] Gal / gal knockout pig skin was completely decellularized after 9 days of continuous treatment with 0.5% SDS. Figures 1A to 1G Porcine skin is shown before...

Embodiment 2

[0127] Example 2: Effect of Porcine Skin Gel (PSG) and Human Peripheral Blood Mononuclear Cells (hPBMC) in Full Thickness Wound Healing

[0128] To determine the wound-healing capacity of PSG, acute full-thickness incision wounds made on the backs of nude mice were treated with no treatment or with HA, PSG alone or PSG+hPBMCs. image 3 The wound healing process of untreated wounds and wounds treated with PSG only or PSG+hPBMCs is shown. On postoperative days 5 and 10, scab formation was observed in all groups. However, at day 15, the scab flaked off in the PSG-treated group and the wound was filled with regenerated skin.

[0129] Wound closure in animals treated with PSG only and PSG+hPBMC

[0130] A clear difference was observed with respect to wound closure in animals treated with PSG and PSG+hPBMC only. On day 15, wounds in these animals exhibited the most pronounced difference in wound closure. On day 15, 5 / 6 (83%, p image 3 As shown, the difference between the control...

Embodiment 3

[0140] Example 3: Human and Host Vascularization of Wounds Accelerates wound healing by promoting neovascularization.

[0141] CD31 staining on postoperative days 5 and 10 showed vascularization in each experimental group. A large number of host (mouse) microvessels can be seen in the PSG+hPBMC treatment group on the 5th and 10th day, and compared with the control group, the microvessel density is much higher (corresponding to Figure 7A , 7D , and 7G). Importantly, many small vessels were positively stained in the PSG+hPBMC-treated group at day 5 when stained with a human-specific anti-CD31 antibody ( Figure 7B ). However, the number of blood vessels positively stained for human CD31 decreased on the 10th day ( Figure 7E ) and is negligible on day 15. This finding indicates that human PBMCs accelerate wound healing by promoting neovascularization.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
widthaaaaaaaaaa
thicknessaaaaaaaaaa
lengthaaaaaaaaaa
Login to View More

Abstract

The present disclosure relates to a composition of an engineered biomaterial including extracellular matrix components of a mammalian tissue and a polymer; method of wound healing; and methods delivering therapeutic agents, growth factors, or hydration for wound healing to a subject in need thereof.

Description

[0001] Cross References to Related Applications [0002] This application claims the benefit of priority to US Provisional Application Serial No. 62 / 249,587, filed November 2, 2015, the entire contents of which are incorporated herein by reference in their entirety. Background technique [0003] As a normal physiological process in the human body, wound healing occurs through four precise and highly programmed phases: hemostasis, inflammation, proliferation and remodeling. For a wound to heal successfully, all four phases must occur in a specific order and time window. Multiple factors can interfere with more than one stage of the process, resulting in poor or impaired wound healing. [0004] Wounds with impaired healing, both delayed acute and chronic wounds, often fail to progress through the normal healing phases. These wounds frequently enter a state of pathological inflammation due to a delayed, incomplete, or uncoordinated healing process. Most chronic wounds are asso...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61L26/00
CPCA61L26/0023A61L26/0052A61L26/0066A61L26/008A61L2300/414A61L26/0057A61P17/02C08L5/08C08L89/06A61L2300/64A61L26/0033A61L26/0047A61L2430/34
Inventor 苏奇特拉·苏米特兰-霍尔格松
Owner 韦里格拉福特公司